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Abstract The use of national, coordinated and compre-
hensive strategies supported by evidence and focused on a
specific cancer is one model for improving cancer control.
The National Breast Cancer Centre (NBCC) was established
in Australia in 1995 to coordinate breast cancer control
initiatives across the country and has successfully achieved a
number of world-firsts in this thirteen year period. Crucial
elements of the initiative have included broad consultation
with key stakeholders, evidence-based focus, addressing
recognized gaps in care, multidisciplinary input including
consumer involvement, innovative approaches, and inde-
pendent operation notwithstanding government funding.
The NBCC’s experience has been extended to ovarian
cancer control and may be useful for others intending to
establish national programs in cancer control.
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Background
Internationally, over 10 million people are diagnosed with
cancer each year with this rate potentially increasing by
50% by 2020 [1]. In May 2005, the World Health
Assembly recommended that all governments develop and
implement comprehensive cancer-control programs utiliz-
ing evidence-based strategies [2].
To alleviate this burden of disease, different countries
have adopted varying approaches across the globe to
implementing programs and policies to improve cancer
control. In England, for example, the National Institute for
Clinical Excellence (NICE) focuses on establishing disease
management guidelines, and auditing practice against these
recommendations to monitor improvements in care in
cancer and other diseases.
One challenge in state or province-based countries with
health systems containing both public and private sectors
has been to undertake a national program that can affect
change across jurisdictions. In America, the approach taken
by the National Comprehensive Cancer Control Program of
the Centers for Disease Control and Prevention is to pro-
vide a focus for existing cancer programs to collaborate
and pool resources [3]. In Canada, the Canadian Strategy
for Cancer Control has provided a collaborative forum for
key cancer groups and government to plan cancer control
strategies.
Given the global impact of cancer and the similarity of
some health care systems, there may be lessons learnt from
the conduct of such programs that would be worth sharing
with those establishing or managing national programs in
cancer control. For example, in 1985 The Europe Against
Cancer program was launched and set the ambitious target
of reducing the expected number of deaths due to cancer by
15% by the year 2000. A program of activities and research
was developed focussing on three major themes: prevention
(particularly tobacco control), screening, and education and
training. Whilst the 15% reduction target was not met across
the European Union, some countries hit the reduction target
(Austria and Finland), while others (Portugal and Greece)
actually had an increase in cancer deaths [4].
National Breast Cancer Centre officially changed its name to the
National Breast and Ovarian Cancer Centre in February 2008.
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The ‘Down Under’ experience
Another approach to cancer programs is to focus on the
control of high incidence cancers in a comprehensive
manner, using strategies to improve awareness and early
detection, lower risk, improve diagnosis, treatment, and
supportive care whilst monitoring disease trends and
outcomes.
In Australia in the early 1990s breast cancer was one
such high incidence cancer, the impact of which was
starting to receive community attention. In 1995, the
Australian Government released the findings of a Parlia-
mentary Inquiry that identified significant issues and
variations in the care of women with breast cancer, such as
the extent to which women were treated by multidisci-
plinary teams and received adequate supportive care and
information [5]. In that year, 10,048 Australian women
were diagnosed with breast cancer and 2,629 women died
from breast cancer [6]. The age-standardized breast cancer
incidence rate was 111.3 per 100,000 population (1997
data) and the age-standardized mortality rate was 27.8 per
100,000 population (1997 data) [6]. A population mam-
mographic screening program was introduced in Australia
in 1991 and was fully implemented by the end of 1995 [7].
The establishment of the BreastScreen Australia program
emphasized a national commitment to the early detection
of breast cancer.
In 1995, the National Breast Cancer Centre (NBCC) was
established in response to the Parliamentary Inquiry as the
first national cancer center with initial start-up funding of
AUD $5 million per annum from the Australian Govern-
ment and recurrent funding of AUD $3 million per annum.
The NBCC has received ongoing bipartisan support since
this time.
Using approaches that were unique in Australia at this
time, the NBCC program used an evidence-based approach
combined with the ‘Plan-Do-Check-Act’ Deming Cycle of
continuous quality improvement to address all aspects of the
breast cancer journey. Input from a wide range of stake-
holders and data monitoring enabled the identification
of priority areas of need or gaps in care, in which system-
atic reviews of international research were conducted to
establish a current evidence-base. The development of
information resources (e.g., clinical practice guidelines/
position statements/consumer guides/information cam-
paigns) were supported by the follow through conduct of
tailored strategies to action improvements. Evaluation of the
effectiveness of interventions and the monitoring of change
provided a feedback loop to initiate new programs of work.
The establishment of a national organization for breast
cancer control provided a focus for a number of efforts in a
range of areas and the opportunity to translate research into
clinical practice. Necessary conditions for broad support of
a new national initiative at the time included key environ-
mental issues, such as the growth of the consumer advocacy
movement, evidence-based medicine increasingly gaining
acceptance amongst clinicians, and increasing frequency of
litigation for missed or delayed diagnoses of breast cancer.
In the initial years, the NBCC conducted the first
national audit of practice in breast cancer care [8] identi-
fying areas, where practice was not in accord with
guideline recommendations and, therefore needed
improvement. In 1995, the audit of the management of over
4,200 breast cancer cases found that hormone receptor
status was not measured in 20% of cases although this was
known to be important information for determining
appropriate endocrine therapy [8]. Despite the known
benefits of radiotherapy following breast conserving sur-
gery, only 41% of women with early disease received
adjuvant radiotherapy [8]. Subsequently, areas selected for
national program strategies included promoting a multi-
disciplinary approach to treatment planning, reporting of
tumor hormone receptor status, and use of radiotherapy
following breast conserving surgery.
There has been a significant improvement in breast
cancer outcomes in Australia in the past decade. In 2004,
the age-standardized mortality rate had fallen to 23.4 per
100,000 population from 29.4 per 100,000 in 1992 [6].
Between 1982–1986 and 1998–2002, five-year survival
following a diagnosis of breast cancer increased from
70.9% to 86.6% [6]. In 2006, the 5-year relative survival
was 98% for women with tumors 10 mm in size or less [9].
It is not possible to determine the independent contri-
bution of the NBCC’s work in breast cancer control. There
are, however, areas where the organization’s work has had
a measurable effect on knowledge, practice, and outcomes.
These areas include providing accurate information to the
public about risk and early detection, improved investiga-
tion of breast symptoms by primary care practitioners,
contributing to improvements in pathology and radiology
reporting, providing evidence-based information about
treatment options to clinicians and women with breast
cancer, improving monitoring of breast cancer control, and
contributing to health service and policy change through
innovative practice models.
The approach used by the NBCC has been acknowl-
edged by government as beneficial and in 2001 the remit
was extended to also improve ovarian cancer control.
Although principally Government funded, the NBCC
operates as an independent company governed by a Board,
staffed by 30 people (primarily located in Sydney) using a
matrix work style within an organizational structure
focused around Executive Management, Programs, Com-
munications and Public Relations, and Administration.
Stakeholder engagement and communications throughout
the country are facilitated by regular face-to-face and
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teleconference meetings, newsletters, email alerts and
updates, and a comprehensive website.
This article intends to summarize the key features of this
Australian program undertaken in a ‘mixed’ public and
private health care system, in a country with urban and
rural regions and within a limited budget. Case studies are
used to further explore possible models for cancer control
strategies and to illustrate how the program has affected
impact across a broad range of areas. Lessons learnt will be
explored to illustrate some of the potential pit falls that can
be experienced when implementing such programs.
Key program attributes
At the outset of the NBCC program, principles and values
were established, many of which have subsequently been
mirrored in the 2002 World Health Organization’s princi-
ples for managing cancer control programs: [10].
Consultative and collaborative
Broad consultation with key stakeholders across the
country including specialists, allied health professionals,
primary care practitioners, people affected by cancer
(consumers), epidemiologists, geneticists, policy makers,
academics, and researchers provides a ‘voice for all’,
national expertise, engages ‘buy-in’, and overcomes per-
ceptions of threat to professional practices. Annual
advisory group meetings, regular fora and working group
meetings facilitate consultation.
Partnerships
Program uptake in a ‘mixed’ health system can be a
challenge. Working with the state health authorities and
state cancer charities provides leverage to action service-
based initiatives and local level activities. Engaging the
private sector (through national associations, individual
services, and clinicians) facilitates the uptake of program
strategies. Engaging rural groups in programs having a
special focus on rural and remote regions (e.g., rural
satellite broadcasts, training workshops for Aboriginal
community health workers, scholarships for rural and
remote nurses) ensures that programs reach regional com-
munities. Working with corporate partners with an aligned
mission can provide leverage to deliver or expand costly
programs (e.g., communication skills training for doctors).
Comprehensive and patient-focused
This inclusive approach described above can be used to
establish work program priorities which cover all aspects
of the patient journey from prevention/risk factors, detec-
tion, diagnosis, treatment, supportive care, follow-up, and
end-of-life issues. Other integral components focus on
national data monitoring (to determine care gaps and
benchmark care improvements) and a communications
stream (to raise public awareness of cancer issues).
Multidisciplinary input
Program capacity can be leveraged through the honorary
commitment of time and expertise of advisors, committee
and working group members from a range of disciplines,
from organizations and individuals, who can subsequently
champion the program work. The inclusion of consumer
representation (see below) was considered ‘novel’ at the
commencement of the program, but is now wide spread
internationally. High level secretariat and administrative
support provided for the organization of meetings signifi-
cantly contributes to the willingness of busy members to
participate.
Informed by consumers
Consumer involvement at a range of levels, from repre-
sentation on the Board of Directors through to
representation on working groups, is integral to establish-
ing priorities and strategic directions and gaining
organizational support from advocates. The program has
been formative in the establishment and close working
relations with Australia’s first national cancer-specific
consumer organization (Breast Cancer Network Australia,
est. 1998), from the organization of the first national con-
sumer conference to the conduct of science and advocacy
training for consumers. This crucial relationship ensures
appropriate consumer representation in all aspects of work
which informs the direction of projects to ensure outcomes
support the needs of women.
Evidence-based
Surveillance of emerging research and systematic reviews
of peer-reviewed published literature is used to support the
development of clinical practice recommendations and
accompanying consumer information. The development of
more than twenty evidence-based guidelines and recom-
mendations covers all stages of the disease continuum from
identification of those at high risk, early detection, diag-
nosis, treatment for in situ, early and advanced disease,
psychosocial care, and the special considerations of
younger women with breast cancer [11–18]. Consumer
input ensures that the psychosocial care as well as the
medical needs of patients are addressed.
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Innovation and continual improvement
Implementation strategies used for improving outcomes
include behavioral, educational, organizational, and policy
approaches determined effective in the research literature
[19–23]. Interventions are evaluated, using methods rang-
ing from questionnaires to randomized controlled trials, to
contribute further to the international body of knowledge
about effective implementation strategies. Strategies are
tailored to target a particular area of need identified
through gap analysis. Strategies implemented can include
audit and feedback, interactive educational workshops,
organizational change in health services, and joint policy
statements. New approaches to care based on emerging
evidence can be trialed and models developed suited to the
local health care environment.
Strategies
In addition to general principles, a number of specific
strategic approaches have been applied.
Public information campaigns
Annual public information campaigns promote key mes-
sages to the general public typically targeting women
without breast cancer. Using a multi-faceted communica-
tions strategy, campaigns can include advertising
(television, printed press, radio), brochures, supermarket
advertising, and local community forums for women across
the country especially in rural areas. Pro-bono placement of
advertising and partnerships formed with other cancer
organizations and corporate groups, such as supermarket
chains and women’s magazines, can help promote the
message given limited financial resources [24]. Strategies
involving primary care practitioners are the key, when
promoting early detection messages. Campaigns for
women of culturally and linguistically diverse backgrounds
target major non-English speaking background communi-
ties using ethnic media, ethnic community groups and
health professionals.
Informing current issues
With the continuous emergence of new research findings, it
is important to inform public debate and improve knowl-
edge about cancer issues with independent comment
through the media. Supporting the popular media by pro-
viding timely comment to TV, radio, and newspaper
journalists about new developments supports the objective
translation of research into meaningful messages.
Opinion leaders and endorsement
Targeting the inclusion of opinion leaders in their respec-
tive fields for membership on committees and working
groups as well as gaining endorsement from key organi-
zations for products or undertakings results in ‘buy-in’ and
ensures long-term ownership of resultant outcomes. With-
out a mandate to work at a local level within services, this
strategy helps with gaining ‘grass roots’ support particu-
larly within the clinical professionals.
Supporting policy development
Providing the federal health minister and the national
government with information about emerging issues, such
as new treatments, is an avenue for facilitating evidence-
based policy development. Whilst not a lobbying or advo-
cacy group, the NBCC program fulfils an advisory role
through membership on key national government strategy
groups and committees informing policy about national
cancer control programs (e.g., population screening). Rec-
ommendations can be made to Government about areas
where changes in reimbursement systems may promote best
practice such as in multidisciplinary care. Similarly, work
with state governments and local service initiatives pro-
motes the uptake of national recommendations.
Informing the research agenda
Based on broad national consultation, the development of
national research priorities provides guidance for investi-
gators and assists research foundations with prioritizing the
allocation of fundraising monies. Collaborative research
initiatives engage individual groups with the national
research agenda. Gap analysis and evidence reviews also
identify outstanding research questions to be provided as
feedback to clinical trials groups. Championing emerging
areas of research, such as health services research, pro-
motes the role of action research in investigating cancer
control.
A number of the above approaches have been recently
identified by the Breast Health Global Initiative as being
feasible for use globally by non-government organizations
including those in limited-resource countries, where inter-
ventions promoting improved outcomes can be introduced
in an incremental manner [25].
Case studies
Case studies are used below to illustrate the application of
the above principles to areas of identified need in the
Australian national program for breast cancer control.
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Case study 1
Improving symptom investigation and referral
in primary care [26]
• Evidence—Clinical practice guidelines recommend that
the ‘triple test approach’ (ie clinical breast examination,
imaging, fine needle aspiration and/or core biopsy) be
used in the investigation of breast symptoms.
• Gap analysis—In Australia, primary care practitioners
are the first ‘port of call’ for women with breast
symptoms. Over half of all breast cancer diagnoses
resulted from the identification of a breast change.
Investigation of breast symptoms in primary care was
inconsistent, leading to delays in diagnosis of breast
cancer [27]. Inconsistency included not ordering all
recommended imaging tests, not conducting diagnostic
tests in the recommended order or simply taking a
‘wait-and-see’ approach. Breast cancer was the most
common cancer to be involved in medical malpractice
with delay in diagnosis being the most frequent reason
for litigation [28].
• Aim—To improve the investigation of women with
breast symptoms by primary care practitioners in line
with evidence-based recommendations.
• Information—A guide is developed specifically for
primary care practitioners providing a step-by-step
process for investigating breast symptoms [13].
• Implementation strategy—Guideline dissemination fol-
lowed by multifaceted strategy including practice audit,
data feedback, and educational interventions.
• Setting—A total of 112 primary care practitioners
randomly selected from across Australia, including
urban and rural practices.
• Evaluation—Pre/post design examining the approaches
used by primary care practitioners to investigating new
breast symptoms before, and five months after receiv-
ing guidelines and implementation program.
• Outcomes—Statistically significant improvements at the
post-test phase for investigation of breast lumps and for
appropriate referral. For example, at pre-intervention,
only 57% of women with suspicious clinical or ultra-
sound findings were referred for mammography. At post-
intervention, referral had increased to 83% [26].
Case study 2
Promoting multidisciplinary care (MDC) model
• Evidence—International studies indicate that breast
cancer outcomes are improved for patients treated in
multidisciplinary settings [29, 30]. Clinical practice
guidelines recommend MDC as optimal care [12, 13].
• Gap analysis—1995 National patterns of care study
indicates 41% of women with breast cancer were
treated by a surgeon who treats less than 20 breast
cancer cases per year [8]. National profile study
indicates lack of MDC in hospitals with a range of
caseloads [31].
• Tailor model to local health care system—International
models of MDC unsuitable for Australian ‘mixed’
health care setting including public/private and urban/
rural sectors. NBCC developed ‘Principles of MDC’ to
provide a framework for a flexible approach to imple-
ment across the Australian health care system [32].
• Innovative implementation—In 2000, a three-year
National demonstration project commenced with three
large collaborative hospital sites across the country to
implement MDC for women with breast cancer [31].
• Evaluation—Included clinician survey, consumer sur-
vey, clinical audit, log of planning meetings and cost
analysis; Sustainability—demonstration sites followed-
up 18 months later; Observational study—anthropolog-
ical investigation of established MDC meetings
generally considered by medical community to be
‘successful’ to determine key characteristics for sites
starting de novo. [31] Barriers identified to MDC
implementation in the demonstration project included
practitioner reimbursement and legal liability of ‘col-
lective’ decision making.
• Information resources—A guide to establishing and
sustaining MDC case planning meetings was developed
using ‘lessons learnt’ from implementation studies.
Guide sent to clinicians and senior hospital service
administrators. A communication skills training module
was developed to assist clinicians with interdisciplinary
team work.
• Broad promotion—A national forum series conducted
with local key clinicians, policy makers, and service
administrators to promote the benefits of MDC and to
workshop strategies to implement MDC in their
settings. Communication skills training component
included. Stakeholder workshops held with medico-
legal experts to establish legal status of team-based case
management planning meetings.
• Public information——Use of annual breast cancer
awareness day to promote message to the public of the
benefits of a ‘care team’.
• Policy impact—Report to federal government about
national demonstration project outcomes recommends
the inclusion of a national reimbursement item to cover
clinicians attending MDC case planning meetings.
• Outcomes—A national audit of MDC in cancer care
conducted in 2006 found that MDC teams existed more
frequently for breast cancer than for other cancers
(report in preparation). Routine attendance by all
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relevant team members at case planning meetings was
inconsistent across the country, however, higher levels
of routine specialist attendance was found in the breast
cancer teams than other cancers. The audit identified
further areas for improvement in implementing this
care model.
• Clinician re-imbursement—Funding item announced by
federal government for case conferencing re-imburse-
ment for cancer specialists from November 2006.
Case study 3
Raising awareness about early detection
• Evidence—International and Australian studies
emphasize the importance of early detection for
improving survival for women diagnosed with breast
cancer. The most commonly detected symptom of
breast cancer is a lump in the breast. More than 50% of
breast cancers are detected by a woman or her doctor as
a result of a change to the look or feel of the breast [8].
• Gap analysis—A national survey of 3,000 ‘well-
women’ in 2003 indicated that Australian women had
a lack of knowledge about breast cancer symptoms
[33]. Only 57% of women identified a breast lump as
their first response when asked about symptoms of
breast cancer and 10% could not name any potential
symptom of breast cancer [33]. Additionally, after
discovering a new breast symptom, 23% of women
reported that they did not see a doctor about the
symptom at all [33]. International and national studies
highlight specific issues for women of culturally and
linguistically diverse backgrounds (CALD) in relation
to breast cancer ‘myths’ which could impact on early
detection [34, 35].
• Public information—Survey results released to mass
media in lead up to Breast Cancer Awareness Month
(October 2005) to create interest about common myths,
misconceptions, and lack of knowledge. Public infor-
mation campaign conducted over nine months to
promote breast awareness was launched by campaign
patron, the Prime Minister’s wife, on Australia’s Breast
Cancer Day (24 October 2005). Extensive campaign
with three main components: (1) Advertising campaign
(TV, radio, print, posters and web) promoting campaign
message ‘‘Breast cancer - Finding it early could save
your life’’, highlighting breast changes to look for and to
see a primary care practitioner if unusual changes are
found [36]. Free advertising placements with a value of
over AU $800,000 were negotiated; (2) Breast Health
Forums held in eleven state capitals and regional and
rural centers around the country. Free public forums
targeted local women who had not had breast cancer to
hear talks by local survivors, local primary care practi-
tioners, and celebrity guests (e.g., national women’s
magazine editor, best-selling female novelist, female TV
news presenter); and (3) Campaign for CALD women
targeting key messages in five key language groups for
Australia (Arabic, Italian, Chinese, Vietnamese, and
Greek) [37]. Campaign developed with specialist multi-
cultural communications consultant including language
translations of information resources, non-English
speaking TV, radio, and print advertising campaign,
dissemination of resources to community groups and
primary care practices, and free-call phone numbers for
women to bi-lingual health consultants.
The public information campaign was run in parallel
with the promotion of breast screening attendance for
asymptomatic women to the national population mam-
mographic screening program.
• Evaluation—Includes online national survey of 2,200
women regarding the awareness advertising campaign,
a survey of 1,047 women attending Breast Health
Forums, reports on dissemination quantities of CALD
resources and inquiries to free-call line, and national
survey of 3,000 ‘well women’ repeated in late 2007 to
investigate knowledge changes.
• Outcomes—Evaluation outcomes indicate wide pene-
tration of campaign messages to women without breast
cancer. Breast Health Forum attendees were in the
target audience with 92% of survey respondents
indicating they were women without breast cancer
and 80% were over 40 years old. About 95% of forum
respondents stated that they had gained new informa-
tion about breast changes that could be breast cancer
and the importance of early detection. About 75% of
forum attendees reported having seen the TV adver-
tisement. Two years after the TV campaign was
commenced, 50% of the respondents to the online
women’s survey remembered the campaign and 64% of
these women could recall the advertisement having a
breast cancer message. The CALD campaign resulted
in the dissemination of over 33,000 translated resources
and over 100 calls to the free-call line. The results of
the national survey of well-women conducted in late
2007 are yet to be released.
Case study 4
Promoting the role of specialist breast care
nurses (BCNs)
• Evidence—Trials from the United Kingdom indicate
that specialist breast care nurses (SBN) have a
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beneficial impact on the care of women with breast
cancer by reducing psychological morbidity, increasing
understanding, recall, patient support, and improving
continuity of care [38, 39]. Women in these studies
received a systematic program of care which included
repeated contact with a SBN during diagnosis and
treatment.
• Gap analysis—A national survey of 544 women with
breast cancer in 1997 indicates that only 25% of
Australian women saw a breast nurse on more than one
occasion during diagnosis and treatment. [40] At
Australia’s first National Breast Cancer Conference
for Women in 1998, coordinated by NBCC, consumers
identify the provision of SBNs as a top priority [41].
Consumers identify that SBNs could be in a unique
position to offer women information, emotional and
practical support at crucial time for women [41].
• Tailor model to local health care system—An evi-
dence-based SBN model of care was developed for the
Australian setting based on national treatment and
psychosocial clinical practice guidelines developed by
the NBCC. The model focused on assessing and
responding to women’s needs and providing continuity
of care.
• Innovative implementation—In 1999, the SBN model
was tested at four hospital-based treatment centers
throughout the country with senior nurses trained to
deliver care in accord with the SBN model. The model
was operationalized in a ‘‘5 in 12’’-clinical pathway
which included five pre-scheduled consultations at
key treatment phases (diagnosis, pre-operative, post-
operative, and two follow-up appointments) across
a 12-week period [42].
• Evaluation—Includes consumer survey (intervention
versus control sample), acceptability and feasibility
study, observational study, and economic feasibility.
Findings indicated that SBN model could be success-
fully implemented across a range of settings and that
the SBNs integrated well into the multidisciplinary
team and played a key role in facilitating women’s
understanding of the MDC team [42]. Women who had
consultations with an SBN were more likely to report
receiving information and emotional support with 88%
of women believing that the SBN had made a
significant contribution to their care [42].
• Professional standards—NBCC developed standards to
define the core competencies of SBN positions to
promote national consistency in the new clinical role
[43]. Educational requirements also established to
ensure consistency of training requirements. Annual
training grant program implemented for rural and
remote nurses to gain exposure to breast cancer courses
and clinical placements.
• Policy impact—There are now over 250 specialist
breast care nurse positions in Australia. In May 2008,
the federal government announced funding of AU $12
million over four years to create 30 new SBN positions
throughout the country.
With the benefit of hindsight
Over the 13 years of undertaking cancer control programs,
there have been a range of lessons learnt about barriers and
enablers. As a federally funded organization, the NBCC
has had to work closely with state jurisdictions, which
administer and fund hospitals within the states. Partnering
with state health authorities and cancer organizations has
provided leverage for programs conducted within these
jurisdictions.
Wanting to run a comprehensive program covering all
aspects of the patient’s cancer journey saw NBCC initially
work in areas in which we now recognize we had little
capacity to effect change. For example, aiming to improve
clinical trial participation rates for women diagnosed with
cancer which in 1995 was at about 3% for early disease [8].
Based on clinical practice guidelines recommending trial
participation [15, 16], the NBCC promoted awareness of
trials through a website for newly diagnosed women and a
discussion paper about women’s participation in trials.
Over the years, it became apparent that the real barrier to
trial participation was in fact more about local infrastruc-
ture in the form of availability and employment of data
managers within local services to support service trial
participation. NBOCC realized that whilst, we could
inform women we had limited ability to break down the
real barrier existing around local resourcing.
Whilst NBCC’s guidelines have been well received and
adopted across a range of cancer areas, development and
revision has been resource intensive and time consuming.
Comprehensive guideline sets covering all aspects of the
management of stages of disease formed a solid foundation
to evidence-based cancer control programs. Maintaining
guideline currency has proven to be a challenge as new
research emerges rapidly particularly in the field of breast
cancer with numerous large international trials underway.
In recent years, we have adopted a ‘topic-specific’
approach to guidelines to ensure that recommendations can
be developed more rapidly whilst still maintaining a rig-
orous evidence-base [44]. The internet has become a major
platform for releasing regular research summaries and
clinical updates to support information currency.
Another barrier to progress has been identified as the
lack of consistency within cancer data collections across
the country. Using the continuous quality improvement
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approach to our program delivery necessitates, having
access to national data to benchmark and monitor progress
in breast cancer control. A barrier to this monitoring
function was identified in the lack of consistency of items
collected in state-based cancer registries and clinical reg-
istries. To improve data collection and reporting, NBCC
has undertaken a number of initiatives to promote cancer
registry consistency throughout the country and agreed
minimum data sets for hospital-based collections.
Summary table
A national cancer control program
• Informed by and responsive to consumer needs—
patient-centered
• Systematic process for research analysis and review—
evidence-based
• Engagement of all key stakeholder groups and opinion
leaders—collaborative approach
• Investigating new models of care—innovative
• Transparent processes—open and representative
• Translation of evidence into clinical practice, service
delivery and policy—outcomes orientated
The result
Through the approach and work outlined above, the NBCC
has earned a reputation as a trusted and authoritative body
for independent evidence-based information for consumers
and health professionals. Government and other funders
regard NBCC as a reliable organization which delivers
high quality outcomes on time, within budget and provides
exceptional value for money. Through the approach
described here, NBCC is now considered a national lead-
ership organization in cancer control which can make a
difference through a comprehensive and effective work
program. The NBCC’s mandate is viewed broadly as
‘translating evidence into information, promoting best
practice and informing policy’.
Building on the experience of breast cancer control
In recognition of successes achieved in breast cancer, the
Australian Government extended the NBCC’s mandate in
2001 to coordinate the first National Ovarian Cancer
Program. Using the same approach, the Program has con-
ducted evidence reviews, disseminated new clinical
practice guidelines and consumer information, developed
information about familial risk, undertaken educational
initiatives, held conferences for stakeholders and the first
national consumer forum for women with ovarian cancer
and their families. In acknowledgement of the incorpora-
tion of this ovarian cancer initiative, NBCC officially
changed its name to the National Breast and Ovarian
Cancer Centre (NBOCC) in February 2008.
Given the leadership role of the NBCC in breast and
ovarian cancer, and the transferability of this approach to
other cancers, there are many gains which can readily be
made through the wider adoption of this model. Recent
programs undertaken by the NBCC have had a broader
cancer focus; including the development of Clinical prac-
tice guidelines for the psychosocial care of adults with
cancer [45], initiatives to promote psychosocial care and
MDC for cancer patients in general and communication
skills training for medical and allied health practitioners.
Where to from here?
In looking forward and in response to stakeholder consul-
tation, the NBOCC will be giving greater focus in its
programs influencing improvements in service delivery and
health policy. Areas planned for future programs include
standards of care for services, exploring new models of
post-surgical care and follow-up, ‘living’ electronic
guidelines, survivorship information needs, promoting
early detection for indigenous women, and supporting
ongoing education for primary care professionals. Whilst
not an advocacy group, the NBOCC has recently estab-
lished a Policy Unit to better inform and respond to
government policy issues including the development of
submissions to parliamentary inquiries and commissions.
The evolution of the NBOCC in response to new
research, changes in cancer outcomes and in the cancer and
health care landscape in Australia provides an opportunity
for other cancer programs to benefit from the experience of
a cancer control initiative conducted ‘Down Under’.
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